Horizon Therapeutics News
News on Horizon Therapeutics (Ticker: MDT) continually updated from thousands of sources around the net.
Medtronic Builds on TAVR Clinical Evidence Portfolio with Five-Year CoreValve Durability Data and Complete Two-Year Outcomes in Intermediate Risk Aortic Stenosis Patients
Updated: Mon Sep 24, 2018 12:57 pm
Copyright © 2018 Topix LLC